http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2021, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Wed, 02 Dec 2020 07:00:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Sio+Gene+Therapies+Announces+First+Patient+Dosed+in+High-Dose+Cohort+of+AXO-AAV-GM1+Clinical+Trial+in+Patients+with+GM1+Gangliosidosis/17671173.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Sio+Gene+Therapies+Announces+First+Patient+Dosed+in+High-Dose+Cohort+of+AXO-AAV-GM1+Clinical+Trial+in+Patients+with+GM1+Gangliosidosis/17671173.html for the full story. http://www.streetinsider.com/Press+Releases/Sio+Gene+Therapies+Announces+First+Patient+Dosed+in+High-Dose+Cohort+of+AXO-AAV-GM1+Clinical+Trial+in+Patients+with+GM1+Gangliosidosis/17671173.html Wed, 02 Dec 2020 07:00:00 -0400 A.32845002 AXGT SIOX http://www.streetinsider.com/Press+Releases/Sio+Gene+Therapies+Announces+First+Patient+Dosed+in+High-Dose+Cohort+of+AXO-AAV-GM1+Clinical+Trial+in+Patients+with+GM1+Gangliosidosis/17671173.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Sio+Gene+Therapies+Announces+First+Patient+Dosed+in+High-Dose+Cohort+of+AXO-AAV-GM1+Clinical+Trial+in+Patients+with+GM1+Gangliosidosis/17671173.html for the full story. http://www.streetinsider.com/Press+Releases/Sio+Gene+Therapies+Announces+First+Patient+Dosed+in+High-Dose+Cohort+of+AXO-AAV-GM1+Clinical+Trial+in+Patients+with+GM1+Gangliosidosis/17671173.html Wed, 02 Dec 2020 07:00:00 -0400 A.32845002 AXGT SIOX http://www.streetinsider.com/Press+Releases/Sio+Gene+Therapies+Announces+First+Patient+Dosed+in+High-Dose+Cohort+of+AXO-AAV-GM1+Clinical+Trial+in+Patients+with+GM1+Gangliosidosis/17671173.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Sio+Gene+Therapies+Announces+First+Patient+Dosed+in+High-Dose+Cohort+of+AXO-AAV-GM1+Clinical+Trial+in+Patients+with+GM1+Gangliosidosis/17671173.html for the full story. http://www.streetinsider.com/Press+Releases/Sio+Gene+Therapies+Announces+First+Patient+Dosed+in+High-Dose+Cohort+of+AXO-AAV-GM1+Clinical+Trial+in+Patients+with+GM1+Gangliosidosis/17671173.html Wed, 02 Dec 2020 07:00:00 -0400 A.32845002 AXGT SIOX http://www.streetinsider.com/Globe+Newswire/Sio+Gene+Therapies+Announces+First+Patient+Dosed+in+High-Dose+Cohort+of+AXO-AAV-GM1+Clinical+Trial+in+Patients+with+GM1+Gangliosidosis/17671173.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Sio+Gene+Therapies+Announces+First+Patient+Dosed+in+High-Dose+Cohort+of+AXO-AAV-GM1+Clinical+Trial+in+Patients+with+GM1+Gangliosidosis/17671173.html for the full story. http://www.streetinsider.com/Globe+Newswire/Sio+Gene+Therapies+Announces+First+Patient+Dosed+in+High-Dose+Cohort+of+AXO-AAV-GM1+Clinical+Trial+in+Patients+with+GM1+Gangliosidosis/17671173.html Wed, 02 Dec 2020 07:00:00 -0400 A.32845002 AXGT SIOX http://www.streetinsider.com/Globe+Newswire/Sio+Gene+Therapies+Announces+First+Patient+Dosed+in+High-Dose+Cohort+of+AXO-AAV-GM1+Clinical+Trial+in+Patients+with+GM1+Gangliosidosis/17671173.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Sio+Gene+Therapies+Announces+First+Patient+Dosed+in+High-Dose+Cohort+of+AXO-AAV-GM1+Clinical+Trial+in+Patients+with+GM1+Gangliosidosis/17671173.html for the full story. http://www.streetinsider.com/Globe+Newswire/Sio+Gene+Therapies+Announces+First+Patient+Dosed+in+High-Dose+Cohort+of+AXO-AAV-GM1+Clinical+Trial+in+Patients+with+GM1+Gangliosidosis/17671173.html Wed, 02 Dec 2020 07:00:00 -0400 A.32845002 AXGT SIOX http://www.streetinsider.com/Globe+Newswire/Sio+Gene+Therapies+Announces+First+Patient+Dosed+in+High-Dose+Cohort+of+AXO-AAV-GM1+Clinical+Trial+in+Patients+with+GM1+Gangliosidosis/17671173.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Sio+Gene+Therapies+Announces+First+Patient+Dosed+in+High-Dose+Cohort+of+AXO-AAV-GM1+Clinical+Trial+in+Patients+with+GM1+Gangliosidosis/17671173.html for the full story. http://www.streetinsider.com/Globe+Newswire/Sio+Gene+Therapies+Announces+First+Patient+Dosed+in+High-Dose+Cohort+of+AXO-AAV-GM1+Clinical+Trial+in+Patients+with+GM1+Gangliosidosis/17671173.html Wed, 02 Dec 2020 07:00:00 -0400 A.32845002 AXGT SIOX http://www.streetinsider.com/Press+Releases/Sio+Gene+Therapies+Appoints+Gene+Therapy+Pioneer+Guangping+Gao%2C+Ph.D.%2C+as+Chief+AAV+Scientific+Advisor/17624314.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Sio+Gene+Therapies+Appoints+Gene+Therapy+Pioneer+Guangping+Gao%2C+Ph.D.%2C+as+Chief+AAV+Scientific+Advisor/17624314.html for the full story. http://www.streetinsider.com/Press+Releases/Sio+Gene+Therapies+Appoints+Gene+Therapy+Pioneer+Guangping+Gao%2C+Ph.D.%2C+as+Chief+AAV+Scientific+Advisor/17624314.html Thu, 19 Nov 2020 08:00:00 -0400 A.26566475 A.32845002 AXGT SIOX http://www.streetinsider.com/Press+Releases/Sio+Gene+Therapies+Appoints+Gene+Therapy+Pioneer+Guangping+Gao%2C+Ph.D.%2C+as+Chief+AAV+Scientific+Advisor/17624314.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Sio+Gene+Therapies+Appoints+Gene+Therapy+Pioneer+Guangping+Gao%2C+Ph.D.%2C+as+Chief+AAV+Scientific+Advisor/17624314.html for the full story. http://www.streetinsider.com/Press+Releases/Sio+Gene+Therapies+Appoints+Gene+Therapy+Pioneer+Guangping+Gao%2C+Ph.D.%2C+as+Chief+AAV+Scientific+Advisor/17624314.html Thu, 19 Nov 2020 08:00:00 -0400 A.26566475 A.32845002 AXGT SIOX http://www.streetinsider.com/Press+Releases/Sio+Gene+Therapies+Appoints+Gene+Therapy+Pioneer+Guangping+Gao%2C+Ph.D.%2C+as+Chief+AAV+Scientific+Advisor/17624314.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Sio+Gene+Therapies+Appoints+Gene+Therapy+Pioneer+Guangping+Gao%2C+Ph.D.%2C+as+Chief+AAV+Scientific+Advisor/17624314.html for the full story. http://www.streetinsider.com/Press+Releases/Sio+Gene+Therapies+Appoints+Gene+Therapy+Pioneer+Guangping+Gao%2C+Ph.D.%2C+as+Chief+AAV+Scientific+Advisor/17624314.html Thu, 19 Nov 2020 08:00:00 -0400 A.26566475 A.32845002 AXGT SIOX http://www.streetinsider.com/Press+Releases/Sio+Gene+Therapies+Appoints+Gene+Therapy+Pioneer+Guangping+Gao%2C+Ph.D.%2C+as+Chief+AAV+Scientific+Advisor/17624314.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Sio+Gene+Therapies+Appoints+Gene+Therapy+Pioneer+Guangping+Gao%2C+Ph.D.%2C+as+Chief+AAV+Scientific+Advisor/17624314.html for the full story. http://www.streetinsider.com/Press+Releases/Sio+Gene+Therapies+Appoints+Gene+Therapy+Pioneer+Guangping+Gao%2C+Ph.D.%2C+as+Chief+AAV+Scientific+Advisor/17624314.html Thu, 19 Nov 2020 08:00:00 -0400 A.26566475 A.32845002 AXGT SIOX http://www.streetinsider.com/Globe+Newswire/Sio+Gene+Therapies+Appoints+Gene+Therapy+Pioneer+Guangping+Gao%2C+Ph.D.%2C+as+Chief+AAV+Scientific+Advisor/17624314.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Sio+Gene+Therapies+Appoints+Gene+Therapy+Pioneer+Guangping+Gao%2C+Ph.D.%2C+as+Chief+AAV+Scientific+Advisor/17624314.html for the full story. http://www.streetinsider.com/Globe+Newswire/Sio+Gene+Therapies+Appoints+Gene+Therapy+Pioneer+Guangping+Gao%2C+Ph.D.%2C+as+Chief+AAV+Scientific+Advisor/17624314.html Thu, 19 Nov 2020 08:00:00 -0400 A.26566475 A.32845002 AXGT SIOX http://www.streetinsider.com/Globe+Newswire/Sio+Gene+Therapies+Appoints+Gene+Therapy+Pioneer+Guangping+Gao%2C+Ph.D.%2C+as+Chief+AAV+Scientific+Advisor/17624314.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Sio+Gene+Therapies+Appoints+Gene+Therapy+Pioneer+Guangping+Gao%2C+Ph.D.%2C+as+Chief+AAV+Scientific+Advisor/17624314.html for the full story. http://www.streetinsider.com/Globe+Newswire/Sio+Gene+Therapies+Appoints+Gene+Therapy+Pioneer+Guangping+Gao%2C+Ph.D.%2C+as+Chief+AAV+Scientific+Advisor/17624314.html Thu, 19 Nov 2020 08:00:00 -0400 A.26566475 A.32845002 AXGT SIOX http://www.streetinsider.com/Globe+Newswire/Sio+Gene+Therapies+Appoints+Gene+Therapy+Pioneer+Guangping+Gao%2C+Ph.D.%2C+as+Chief+AAV+Scientific+Advisor/17624314.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Sio+Gene+Therapies+Appoints+Gene+Therapy+Pioneer+Guangping+Gao%2C+Ph.D.%2C+as+Chief+AAV+Scientific+Advisor/17624314.html for the full story. http://www.streetinsider.com/Globe+Newswire/Sio+Gene+Therapies+Appoints+Gene+Therapy+Pioneer+Guangping+Gao%2C+Ph.D.%2C+as+Chief+AAV+Scientific+Advisor/17624314.html Thu, 19 Nov 2020 08:00:00 -0400 A.26566475 A.32845002 AXGT SIOX http://www.streetinsider.com/Globe+Newswire/Sio+Gene+Therapies+Appoints+Gene+Therapy+Pioneer+Guangping+Gao%2C+Ph.D.%2C+as+Chief+AAV+Scientific+Advisor/17624314.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Sio+Gene+Therapies+Appoints+Gene+Therapy+Pioneer+Guangping+Gao%2C+Ph.D.%2C+as+Chief+AAV+Scientific+Advisor/17624314.html for the full story. http://www.streetinsider.com/Globe+Newswire/Sio+Gene+Therapies+Appoints+Gene+Therapy+Pioneer+Guangping+Gao%2C+Ph.D.%2C+as+Chief+AAV+Scientific+Advisor/17624314.html Thu, 19 Nov 2020 08:00:00 -0400 A.26566475 A.32845002 AXGT SIOX http://www.streetinsider.com/Press+Releases/Sio+Gene+Therapies+Announces+Corporate+Updates+and+Financial+Results+for+Second+Fiscal+Quarter+Ended+September+30%2C+2020/17597009.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Sio+Gene+Therapies+Announces+Corporate+Updates+and+Financial+Results+for+Second+Fiscal+Quarter+Ended+September+30%2C+2020/17597009.html for the full story. http://www.streetinsider.com/Press+Releases/Sio+Gene+Therapies+Announces+Corporate+Updates+and+Financial+Results+for+Second+Fiscal+Quarter+Ended+September+30%2C+2020/17597009.html Fri, 13 Nov 2020 07:00:00 -0400 A.06822034 A.24736300 A.32845002 AXGT SIOX http://www.streetinsider.com/Press+Releases/Sio+Gene+Therapies+Announces+Corporate+Updates+and+Financial+Results+for+Second+Fiscal+Quarter+Ended+September+30%2C+2020/17597009.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Sio+Gene+Therapies+Announces+Corporate+Updates+and+Financial+Results+for+Second+Fiscal+Quarter+Ended+September+30%2C+2020/17597009.html for the full story. http://www.streetinsider.com/Press+Releases/Sio+Gene+Therapies+Announces+Corporate+Updates+and+Financial+Results+for+Second+Fiscal+Quarter+Ended+September+30%2C+2020/17597009.html Fri, 13 Nov 2020 07:00:00 -0400 A.06822034 A.24736300 A.32845002 AXGT SIOX http://www.streetinsider.com/Press+Releases/Sio+Gene+Therapies+Announces+Corporate+Updates+and+Financial+Results+for+Second+Fiscal+Quarter+Ended+September+30%2C+2020/17597009.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Sio+Gene+Therapies+Announces+Corporate+Updates+and+Financial+Results+for+Second+Fiscal+Quarter+Ended+September+30%2C+2020/17597009.html for the full story. http://www.streetinsider.com/Press+Releases/Sio+Gene+Therapies+Announces+Corporate+Updates+and+Financial+Results+for+Second+Fiscal+Quarter+Ended+September+30%2C+2020/17597009.html Fri, 13 Nov 2020 07:00:00 -0400 A.06822034 A.24736300 A.32845002 AXGT SIOX http://www.streetinsider.com/Press+Releases/Sio+Gene+Therapies+Announces+Corporate+Updates+and+Financial+Results+for+Second+Fiscal+Quarter+Ended+September+30%2C+2020/17597009.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Sio+Gene+Therapies+Announces+Corporate+Updates+and+Financial+Results+for+Second+Fiscal+Quarter+Ended+September+30%2C+2020/17597009.html for the full story. http://www.streetinsider.com/Press+Releases/Sio+Gene+Therapies+Announces+Corporate+Updates+and+Financial+Results+for+Second+Fiscal+Quarter+Ended+September+30%2C+2020/17597009.html Fri, 13 Nov 2020 07:00:00 -0400 A.06822034 A.24736300 A.32845002 AXGT SIOX http://www.streetinsider.com/Press+Releases/Sio+Gene+Therapies+Announces+Corporate+Updates+and+Financial+Results+for+Second+Fiscal+Quarter+Ended+September+30%2C+2020/17597009.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Sio+Gene+Therapies+Announces+Corporate+Updates+and+Financial+Results+for+Second+Fiscal+Quarter+Ended+September+30%2C+2020/17597009.html for the full story. http://www.streetinsider.com/Press+Releases/Sio+Gene+Therapies+Announces+Corporate+Updates+and+Financial+Results+for+Second+Fiscal+Quarter+Ended+September+30%2C+2020/17597009.html Fri, 13 Nov 2020 07:00:00 -0400 A.06822034 A.24736300 A.32845002 AXGT SIOX http://www.streetinsider.com/Globe+Newswire/Sio+Gene+Therapies+Announces+Corporate+Updates+and+Financial+Results+for+Second+Fiscal+Quarter+Ended+September+30%2C+2020/17597009.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Sio+Gene+Therapies+Announces+Corporate+Updates+and+Financial+Results+for+Second+Fiscal+Quarter+Ended+September+30%2C+2020/17597009.html for the full story. http://www.streetinsider.com/Globe+Newswire/Sio+Gene+Therapies+Announces+Corporate+Updates+and+Financial+Results+for+Second+Fiscal+Quarter+Ended+September+30%2C+2020/17597009.html Fri, 13 Nov 2020 07:00:00 -0400 A.06822034 A.24736300 A.32845002 AXGT SIOX http://www.streetinsider.com/Globe+Newswire/Sio+Gene+Therapies+Announces+Corporate+Updates+and+Financial+Results+for+Second+Fiscal+Quarter+Ended+September+30%2C+2020/17597009.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Sio+Gene+Therapies+Announces+Corporate+Updates+and+Financial+Results+for+Second+Fiscal+Quarter+Ended+September+30%2C+2020/17597009.html for the full story. http://www.streetinsider.com/Globe+Newswire/Sio+Gene+Therapies+Announces+Corporate+Updates+and+Financial+Results+for+Second+Fiscal+Quarter+Ended+September+30%2C+2020/17597009.html Fri, 13 Nov 2020 07:00:00 -0400 A.06822034 A.24736300 A.32845002 AXGT SIOX http://www.streetinsider.com/Globe+Newswire/Sio+Gene+Therapies+Announces+Corporate+Updates+and+Financial+Results+for+Second+Fiscal+Quarter+Ended+September+30%2C+2020/17597009.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Sio+Gene+Therapies+Announces+Corporate+Updates+and+Financial+Results+for+Second+Fiscal+Quarter+Ended+September+30%2C+2020/17597009.html for the full story. http://www.streetinsider.com/Globe+Newswire/Sio+Gene+Therapies+Announces+Corporate+Updates+and+Financial+Results+for+Second+Fiscal+Quarter+Ended+September+30%2C+2020/17597009.html Fri, 13 Nov 2020 07:00:00 -0400 A.06822034 A.24736300 A.32845002 AXGT SIOX http://www.streetinsider.com/Globe+Newswire/Sio+Gene+Therapies+Announces+Corporate+Updates+and+Financial+Results+for+Second+Fiscal+Quarter+Ended+September+30%2C+2020/17597009.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Sio+Gene+Therapies+Announces+Corporate+Updates+and+Financial+Results+for+Second+Fiscal+Quarter+Ended+September+30%2C+2020/17597009.html for the full story. http://www.streetinsider.com/Globe+Newswire/Sio+Gene+Therapies+Announces+Corporate+Updates+and+Financial+Results+for+Second+Fiscal+Quarter+Ended+September+30%2C+2020/17597009.html Fri, 13 Nov 2020 07:00:00 -0400 A.06822034 A.24736300 A.32845002 AXGT SIOX http://www.streetinsider.com/Globe+Newswire/Sio+Gene+Therapies+Announces+Corporate+Updates+and+Financial+Results+for+Second+Fiscal+Quarter+Ended+September+30%2C+2020/17597009.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Sio+Gene+Therapies+Announces+Corporate+Updates+and+Financial+Results+for+Second+Fiscal+Quarter+Ended+September+30%2C+2020/17597009.html for the full story. http://www.streetinsider.com/Globe+Newswire/Sio+Gene+Therapies+Announces+Corporate+Updates+and+Financial+Results+for+Second+Fiscal+Quarter+Ended+September+30%2C+2020/17597009.html Fri, 13 Nov 2020 07:00:00 -0400 A.06822034 A.24736300 A.32845002 AXGT SIOX http://www.streetinsider.com/Press+Releases/Axovant+Gene+Therapies+Announces+Name+Change+to+Sio+Gene+Therapies/17578505.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Axovant+Gene+Therapies+Announces+Name+Change+to+Sio+Gene+Therapies/17578505.html for the full story. http://www.streetinsider.com/Press+Releases/Axovant+Gene+Therapies+Announces+Name+Change+to+Sio+Gene+Therapies/17578505.html Tue, 10 Nov 2020 07:00:00 -0400 A.08677828 A.09642568 A.24736300 AXGT